Sinopep-Allsino
688076.SSSinopep-Allsino Bio Pharmaceutical Co.,Ltd. Price (688076.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
214,389,612
(0.5656)%Cash Flow Statement
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.Currency: CNY
| YEAR | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -13,635,903.59
+0% |
-25,157,144.65
+84% |
-30,153,958.24
+20% |
-74,797,496.00
+148% |
41.93M
-156% |
44.68M
+7% |
44.81M
+0% |
120.03M
+168% |
108.81M
-9% |
122.77M
+13% |
162.94M
+33% |
||||||||
| Depreciation And Amortiz... | 3.41M | 9.45M | 9.70M | 10.75M | 18.83M | 23.91M | 41.63M | 70.71M | 84.77M | 99.96M | 135.55M | ||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | -1,507,275.00 | -28,758,400.00 | -4,434,100.00 | 3.95M | 9.13M | -4,867,975.00 | 0.00 | ||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 27.85M | 0.00 | 447.00k | 6.70M | 6.48M | 5.79M | 460.80k | 0.00 | ||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | 1.62M | 486.96k | 6.12M | -29,139,956.00 | 39.97M | -33,613,500.00 | -42,316,400.00 | -45,878,698.00 | -145,035,863.00 | -126,486,832.00 | ||||||||
| Accounts Payables | 0.00 | 0.00 | 0.00 | 3.34M | -15,815,101.00 | 19.87M | -7,844,200.00 | 30.26M | 75.82M | 58.34M | 180.38M | ||||||||
| Inventory | 3.42k | 57.50k | -3,839,647.69 | -261,241.00 | -15,307,960.78 | -17,869,087.35 | -20,677,528.51 | -73,430,481.44 | -87,625,696.52 | -111,735,524.68 | -82,583,118.00 | ||||||||
| Other Working Capital | 51.71M | 78.89M | -93,323,716.14 | 27.85M | -46,462,334.16 | 31.08M | -4,434,118.52 | 3.95M | 9.13M | -4,867,975.48 | -13,564,409.11 | ||||||||
| Other Non-Cash Items | 2.18M | 4.94M | 5.00M | 45.19M | 12.12M | 14.25M | 24.01M | 21.74M | 20.80M | 8.16M | 93.98M | ||||||||
| Net Cash Provided By Op... | 43.67M
+0% |
68.18M
+56% |
-112,624,908.87
-265% |
-21,951,560.00
-81% |
11.11M
-151% |
96.06M
+765% |
46.14M
-52% |
141.38M
+206% |
180.75M
+28% |
29.29M
-84% |
350.21M
+1,096% |
||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -24,629,174.94 | -9,688,913.07 | -12,070,929.80 | -11,138,778.00 | -73,339,173.29 | -197,484,031.92 | -276,387,801.09 | -111,283,537.21 | -233,355,948.50 | -438,362,527.44 | -660,639,130.00 | ||||||||
| Acquisitions Net | 0.00 | 0.00 | 0.00 | 8.91k | 152.95k | -13,780,519.38 | 276.63M | 17.00M | 339.94k | 13.12M | 0.00 | ||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | -71,300,000.00 | -75,000,000.00 | -436,000,000.00 | -86,000,000.00 | -176,000,000.00 | -914,000,000.00 | -724,950,000.00 | -556,500,000.00 | ||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 71.30M | 75.36M | 436.79M | 86.43M | 95.65M | 910.09M | 700.39M | 553.40M | ||||||||
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 94.19k | 25.07M | 171.40k | -276,387,800.89 | 11.46M | 1.64 | 56.18k | 1.53M | ||||||||
| Net Cash Used For Inv... | -24,629,174.94
+0% |
-9,688,913.07
-61% |
-12,070,929.80
+25% |
-11,129,873.00
-8% |
-47,760,713.57
+329% |
-210,307,410.05
+340% |
-275,713,800.98
+31% |
-163,175,126.18
-41% |
-236,930,709.86
+45% |
-449,743,026.47
+90% |
-662,208,812.99
+47% |
||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | -6,820,000.00 | -59,030,000.00 | 33.70M | -4,934,747.00 | 54.48M | -113,694,347.00 | 116.33M | 52.13M | -180,115,707.00 | 260.92M | 696.29M | ||||||||
| Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 762.63M | 0.00 | 0.00 | ||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -762,629,380.00 | 0.00 | 0.00 | ||||||||
| Dividends Paid | -6,585,444.82 | -5,095,264.85 | -4,424,356.55 | 0.00 | -59,113,110.79 | -8,384,409.89 | -4,470,000.00 | -11,631,662.80 | -6,043,220.00 | -31,977,570.00 | -57,614,716.00 | ||||||||
| Other Financing Activities | 0.00 | 0.85 | 125.35M | 5.81M | 59.21M | 404.58M | -13,264,247.00 | -997,687.20 | 721.05M | 7.97M | -6,780,436.00 | ||||||||
| Net Cash Used/Provide... | -13,405,444.82
+0% |
-64,125,264.85
+378% |
154.63M
-341% |
875.57k
-99% |
54.58M
+6,133% |
284.48M
+421% |
98.59M
-65% |
39.50M
-60% |
534.89M
+1,254% |
236.91M
-56% |
631.90M
+167% |
||||||||
| Effect Of Forex Changes... | -17.55 | -2,224.44 | 1.27k | 0.00 | -274,235.81 | -464,026.66 | -132,994.47 | -7,733,328.09 | -1,578,314.90 | -816,164.73 | -3,213,148.00 | ||||||||
| Net Change In Cash | 5.64M | -5,639,647.00 | 29.93M | -32,205,864.00 | 17.65M | 169.77M | -131,119,600.00 | 9.98M | 477.13M | -184,354,231.00 | 316.69M | ||||||||
| Cash At Beginning Of Per... | 4.07M | 9.71M | 4.07M | 34.00M | 1.79M | 19.44M | 189.22M | 58.10M | 68.07M | 545.20M | 360.84M | ||||||||
| Cash At End Of Period | 9.71M | 4.07M | 34.00M | 1.79M | 19.44M | 189.22M | 58.10M | 68.07M | 545.20M | 360.84M | 677.53M | ||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 43.67M | 68.18M | -112,624,908.87 | -21,951,560.00 | 11.11M | 96.06M | 46.14M | 141.38M | 180.75M | 29.29M | 350.21M | ||||||||
| Capital Expenditure | -24,629,174.94 | -9,688,913.07 | -12,070,929.80 | -11,138,778.00 | -73,339,173.29 | -197,484,031.92 | -276,387,801.09 | -111,283,537.21 | -233,355,948.50 | -438,362,527.44 | -660,639,130.78 | ||||||||
| Free Cash Flow | 19.04M
+0% |
58.49M
+207% |
-124,695,838.67
-313% |
-33,090,338.00
-73% |
-62,229,103.29
+88% |
-101,426,588.92
+63% |
-230,251,868.09
+127% |
30.10M
-113% |
-52,609,749.50
-275% |
-409,070,441.44
+678% |
-310,425,312.83
-24% |
||||||||